Erlocip (Erlotinib)

✅ Key Benefits

• Blocks EGFR signaling to inhibit cancer progression

• Effective in EGFR-mutant NSCLC patients

• Oral daily dosing supports outpatient treatment

• Proven to improve progression-free survival

• Manageable side effect profile under physician care

🎯 How to Use

• Adults: Typically 150 mg once daily on an empty stomach

• Swallow tablet with water—do not crush or chew

• Take at consistent time each day

• Monitor liver function, rash, diarrhea, and lung symptoms

• Store in a cool, dry place away from children

⚠️ Precautions

• Prescription-only targeted therapy—use under specialist supervision

• Monitor for liver toxicity, pulmonary symptoms, and skin rash

• Avoid during pregnancy or breastfeeding

• Check for drug interactions (e.g., warfarin, PPIs, St. John’s Wort)

• Discontinue and consult provider if severe diarrhea, hepatic dysfunction, or interstitial lung disease occurs

🤕 Possible Side Effects

• Common: Rash, diarrhea, anorexia, fatigue, nausea

• Occasional: Elevated liver enzymes, insomnia, cough

• Rare but serious: Interstitial lung disease, severe hepatic injury—seek immediate care if these develop

🎁 The Medicine Villa Special Offers

• 🏷️ Flat 50% OFF – Use Coupon Code: TMV50

• 🚚 Free USA Shipping on orders over $199

• 📦 USA to USA Delivery in 3–4 Days for oncology items

• 🔒 Secure Checkout & Discreet Medical Packaging

❓ Frequently Asked Questions (FAQs)

Q. What is Erlocip used for?
A. Treats EGFR-mutant non-small cell lung cancer by inhibiting EGFR tyrosine kinase.

Q. How should it be taken?
A. 150 mg once daily on an empty stomach; consistent daily dosing is important.

Q. Are any tests required during treatment?
A. Yes—regular monitoring of liver function, pulmonary status, and dermatologic effects is needed.

Q. Can it be used during pregnancy?
A. No—contraindicated; avoid use during pregnancy or breastfeeding.